Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease-Reference-Cited by-同舟云学术

Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease

Published:2016-10 Issue: Volume:94 Page:95-105
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Padel Thomas,Özen Ilknur,Boix Jordi,Barbariga Marco,Gaceb Abderahim,Roth Michaela,Paul Gesine

Funder

Swedish Medical Research Council

European Union

Publisher

Elsevier BV

Subject

Neurology

Reference47 articles.

1. Endothelial/pericyte interactions;Armulik;Circ. Res.,2005

2. Pericytes regulate the blood-brain barrier;Armulik;Nature,2010

3. Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration;Barcia;Parkinsonism Relat. Disord.,2005

4. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization;Berger;Blood,2005

5. Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism;Blume;Exp. Neurol.,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy;Translational Neurodegeneration;2024-07-29

2. Pericyte response to ischemic stroke precedes endothelial cell death and blood-brain barrier breakdown;Journal of Cerebral Blood Flow & Metabolism;2024-07-25

3. Revealing the mechanisms of blood–brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention;Reviews in the Neurosciences;2024-07-08

4. A Water-soluble Form of Dihydroquercetin Reduces LPS-induced Astrogliosis, Vascular Remodeling, and mRNA VEGF-A Levels in the Substantia Nigra of Aged Rats;Journal of Neuroscience and Neurological Disorders;2024-02-16

5. The future neurotrophic factor therapy in Parkinson's disease;International Review of Movement Disorders;2024